author-photo

Mark D. Rothmann

Food and Drug Administration

30

Papers

1926

Citations

Citation Trend

Filter By

Papers (18) Sort By

Journal Conference Others

Active Control Trials

2018
Show All
- Source
- Cite
- Save
Citations (0)
Evaluating the Active Control Effect

2016
Show All
- Source
- Cite
- Save
Citations (0)
Inference on Proportions

2016
Show All
- Source
- Cite
- Save
Citations (0)
Inferences on Means and Medians

2016
Show All
- Source
- Cite
- Save
Citations (0)
- What Is a Non-Inferiority Trial?

2016
Show All
- Source
- Cite
- Save
Citations (0)
- Inference on Time-to-Event Endpoints

2016
Show All
- Source
- Cite
- Save
Citations (0)
Strength of Evidence and Reproducibility

2016
Show All
- Source
- Cite
- Save
Citations (0)
U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma

2012 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (157)
U.S. Food and Drug Administration Approval: Ruxolitinib for the Treatment of Patients with Intermediate and High-Risk Myelofibrosis

2012 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (90)
U.S. Food and Drug Administration Approval: Rituximab in Combination with Fludarabine and Cyclophosphamide for the Treatment of Patients with Chronic Lymphocytic Leukemia

2011 Oncologist
Show All
- Source
- Cite
- Save
Citations (27)